Agios Pharmaceuticals, Inc. (0HB0.L) LSE

28.39

+0.82(+2.97%)

Updated at December 05 07:28AM

Currency In USD

Valuation

Market Cap1.87B
Enterprise Value1.85B
P/E Ratio-3.97
PEG Ratio0.02
Price/Sales Ratio35.7
Price/Book Ratio1.24
Enterprise/Revenue34.62
Enterprise/EBITDA-3.51

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-8.96
Operating Margin-10.62

Management Effectiveness

Return On Assets-0.29
Return On Equity-0.28

Income Statement

Revenue36.5M
Revenue/Share0.77
Gross Profit26.68M
EBITDA723.62M
Net Income673.73M
Diluted EPS11.64

Balance Sheet

Total Cash952.86M
Total Cash/Share16.39
Total Debt44.52M
Total Debt/Equity0.03
Current Ratio13.82
Book Value Per Share22.09

Price History

52-Week Change-53.47
52-Week High35.35
52-Week Low20.13
Moving Average 50 Days26.18
Moving Average 200 Days24.83

Statistics

Average Volume522
Shares Outstanding58.18M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A